Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

545.53
+3.010.55%
Post-market: 547.001.47+0.27%17:17 EDT
Volume:708.60K
Turnover:387.86M
Market Cap:58.90B
PE:13.84
High:552.98
Open:543.44
Low:542.50
Close:542.52
Loading ...
May 29, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 29, 2020

Major Issues Report

8-K - Current report
May 26, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 26, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 05, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 05, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 07, 2020

Major Issues Report

Current report, item 1.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 06, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Jan 13, 2020

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Dec 09, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Nov 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Nov 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Nov 08, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Nov 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 05, 2019

Major Issues Report

Current report, items 2.02 and 9.01